Correction to ‘Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in apoE−/− mice’
IF 5.3
引用次数: 0
Abstract
Wu Y, Song F, Li Y, et al. Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in apoE-/- mice. J Cell Mol Med. 2021; 25: 521–534. doi: 10.1111/jcmm.16106
In the article, the second sentence of the Abstract reads “Acacetin, an anti-inflammatory and antiarrhythmic, is frequently used in the treatment of myocarditis, albeit its role in managing atherosclerosis is currently unclear.” is correct. This should read “Acacetin is antiarrhythmic and anti-inflammatory, which is experimentally used in treating myocardial injury.”. The authors confirm all results and conclusions of this article remain unchanged.
We apologize for this error.
对 "Acacetin 通过 Nrf2 通路在 apoE-/- 小鼠体内发挥抗氧化潜力，防止动脉粥样硬化 "的更正。
Wu Y, Song F, Li Y, et al. Acacetin 通过 Nrf2 通路在载脂蛋白 E-/- 小鼠体内发挥抗氧化潜力以防治动脉粥样硬化。J Cell Mol Med.2021；25：521-534。DOI：10.1111/jcmm.16106在文章中，摘要第二句 "阿卡西汀是一种抗炎和抗心律失常药物，常用于治疗心肌炎，尽管其在控制动脉粥样硬化方面的作用目前尚不清楚。"是正确的。应改为 "Acacetin 具有抗心律失常和抗炎作用，实验中用于治疗心肌损伤"。作者确认本文的所有结果和结论保持不变。我们对这一错误表示歉意。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
CiteScore
11.50
自引率
0.00%
发文量
0
期刊介绍：
The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries.
It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
